Tandem Diabetes Care (NASDAQ:TNDM) reported quarterly earnings results on February 19, 2026 that exceeded analyst expectations.
The Healthcare company reported earnings per share of $-0.01, beating the consensus estimate of $-0.07 by $0.06 per share. Revenue came in at $290.4M, beating the estimate of $276.7M.
Tandem Diabetes Care's stock moved following the earnings release. The stock currently trades at $24.57 with a market capitalization of $1.4B.